Arcutis Biotherapeutics had a revenue of 65.85M in the quarter ending Mar 31, 2025, with -7.73%. This bring the company's revenue in the last twelve months to 212.82M, Decreased 8.28%. In the fiscal year ending Dec 31, 2024, Arcutis Biotherapeutics had annual revenue of 196.54M with 229.74% growth.